of Gd(L 4 ). With respect to the analogous neutral complexes, the negative charge induces a significant rigidity of the micelles formed, which is reflected by slower and more restricted local motion of the Gd 3+ centers as evidenced by higher relaxivities at 20-60 MHz. Surface Plasmon Resonance results indicate that the charge does not affect significantly the binding strength to Aβ 1-40 [K d = 194 ± 11 μM for La(L 4 )], but it does enhance the affinity constant to human serum albumin [K a = 6530 ± 68 M −1 for Gd(L 4 )], as compared to neutral counterparts. Protein-based NMR points to interaction of Gd(L 4 ) with Aβ 1-40 in the monomer state as well, in contrast to neutral complexes interacting only with the aggregated form. Circular dichroism spectroscopy monitored time-and temperature-dependent changes of the Aβ 1-40 secondary structure, indicating that Gd(L 4 ) stabilizes the random coil relative to the α-helix and β-sheet. TEM images confirm that the Gd(L 4 ) complex reduces the formation of aggregated fibrils.
Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disorder responsible for 60-70 % of dementia cases [1] [2] [3] . The diagnosis of AD is mainly based on cognitive tests and can be ascertained post-mortem only [4] . The development of diagnostic imaging agents for early in vivo detection of the amyloid plaques is critical both for diagnosis and the monitoring of new therapies [5] . Representative neuropathological markers of AD are the brain deposition of intracellular neurofibrillary tangles, caused by the hyperphosphorylation of tau proteins, and of extracellular neuritic plaques, caused by the aggregation of amyloid β-peptide (Aβ) fibrils [6, 7] . Amyloid plaques are mainly composed of Aβ and Aβ peptides cleaved from the misregulated amyloid-β precursor protein (APP) [6] . According to the "Amyloid Hypothesis" [8] , Aβ plaques appear one to two decades before the first clinical symptoms of AD. Therefore, innovative imaging probes that detect amyloid plaques are needed to identify persons at risk and to monitor the effects of prophylactics and the course of the disease [9] . In 2014, two large clinical trials with humanized antibodies that bind Aβ and lower its concentration in vivo failed to show cognitive benefits [10, 11] . Whereas these results were interpreted by some as casting doubt on the Amyloid Hypothesis, others believe that earlier treatment might well have successfully prevented the disease [12] . The recent finding that Aβ plaques from one person can cause AD in a second, decades after an unlucky injection [13] provides new support for the Amyloid Hypothesis and further highlights the need for better diagnostic probes.
The most significant progress so far has been made in Positron Emission Tomography (PET). Small organic compounds, such as benzoxazoles, benzothiazoles and stilbenes, show good blood-brain-barrier (BBB) permeability and high binding affinity for Aβ aggregates. Their 11 C-and 18 F-labeled derivatives have been successfully explored as amyloid-targeted PET probes [14] [15] [16] [17] , and some are currently in clinical trials [15] [16] [17] [18] [19] [20] [21] . The thioflavin-T (Th-T)-derivative [ 11 C]-PIB (Pittsburg compound B) [14, 15, [22] [23] [24] , currently in phase III clinical trials, is considered the gold standard amyloid PET tracer often used as a reference to compare the efficiency of new markers of Aβ plaques [25] . Given the easier accessibility of 99m Tc as compared to 11 C and 18 F, several small, neutral 99m
Tc-labeled Aβ binding probes [26] [27] [28] [29] [30] [31] have been proposed for AD detection using Single Photon Emission Computed Tomography (SPECT). The radiolabel Tc is complexed by a ligand which is coupled via a spacer to the amyloid-targeting moiety [32, 33] . Some of these probes showed reasonable brain uptake and affinity towards β-amyloid plaques. A similar approach based on 64 Cu-labeled bifunctional chelates conjugated to stilbenes as PET probes has been pursued [33] .
Despite this progress in in vivo nuclear imaging of AD, there is a need for novel applications based on less invasive imaging techniques with better resolution. The excellent resolution of Magnetic Resonance Imaging (MRI) could be relevant for detection of small amyloid lesions and quantifying amyloid deposits for the evaluation of new early stage AD treatments. Other important advantages of MRI relative to nuclear techniques are the lower cost, wider availability and mostly the absence of radiation burden. Despite this, the development of MRI probes for the detection of AD biomarkers has been less successful. This is mainly due to the low sensitivity of MRI which requires higher quantities of the probe to be delivered via the blood-brain-barrier, and hence only pre-clinical probes have been proposed so far. The intrinsic MRI contrast can be efficiently enhanced by paramagnetic contrast agents (CAs), mainly Gd 3+ -chelates or iron-oxide nanoparticles [34] . Complexes of Gd 3+ are the most widely used MRI CA which ensure positive contrast [34, 35] . Their efficacy is measured by the relaxivity, defined as the paramagnetic enhancement of the water proton relaxation rate, normalized to 1 mM Gd 3+ concentration [34, 35] . Relaxivity is related to the hydration number (q), the rotational correlation time (τ R ), the water exchange rate (k ex ) and the electron spin relaxation times (T 1,2e ) of the Gd 3+ complex [34] .
In the absence of a CA, the MR contrast in the amyloid plaques in an advanced stage of AD is provided by iron accumulation in the plaques, which leads to hypointense spots in T 2 , T 2 * or susceptibility-weighted images [36] . MRI studies using CAs reported to visualize AD plaques in transgenic mice include the use of 19 F-labeled compounds for 19 F MRI [37] , Gd 3+ complexes or USPIO conjugated with modified human Aβ or human Aβ peptide (e.g., with putrescine) able to cross the BBB [38] [39] [40] [41] [42] [43] , or USPIO conjugated with Aβ-specific peptides selected via phage display [44] . Although these structural modifications improved the BBB permeability without affecting the binding to amyloid deposits, these probes did not cross the BBB enough to detect the amyloid plaques in the transgenic mouse brain in vivo by MRI. Therefore, adjuvants such as mannitol were used to transiently open the BBB, which prevents human application. For these reasons, new types of CA need to be developed.
Amyloid deposits in the brain of AD transgenic mice have been detected by MRI after intracerebroventricular injection of a non-targeted, clinically used CA GdDOTA (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), showing that when small CAs reach the brain, the amyloid deposits can be imaged [45] . A new generation of low molecular weight Gd 3+ -based CAs designed to detect the 1 3 amyloid deposits by MRI has been recently developed. These probes are constituted of three parts: a Gd 3+ -complex as imaging moiety, an amyloid binding ligand as biovector and a linker between these two moieties. We have previously reported a family of three ligands for the design of multimodal imaging agents where a PiB moiety was conjugated through different linkers to a DO3A-monoamide (L 1 , L 2 and L 3 , Scheme 1) [46] [47] [48] . This metal chelating unit efficiently coordinates various trivalent metal ions to yield non-charged complexes that can act as imaging agents in different modalities, like Gd 3+ for MRI,
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In 3+ for SPECT or 68 Ga 3+ for PET. In spite of a moderate binding affinity for Aβ aggregates (K d = 67-170 mM) [48] , the Eu 3+ derivative showed to successfully and selectively label the amyloid deposits in postmortem human brain tissues of AD patients [46] . However, based on in vivo biodistribution data, the BBB permeability of the CA was expected to be insufficient for in vivo MRI detection. The solubility and the parameters determining the relaxivity of the Gd 3+ derivatives were successfully tuned by modifying the linker between the Gd 3+ chelate and the PIB derivative [47] . A GdDTPA curcumin conjugate [49] and a series of 16 GdPCTA (H 3 PCTA = 3,6,9,15-tetraaza bicyclo[9.3.1]-pentadeca-1(15),11,13-triene-3,6,9-triacetic acid) and GdDOTA chelates conjugated to three different biovectors (derivatives of PiB, a benzoxazole analog and stilbene), using different types of linkers with neutral, positive or negative charge(s) [50] , have also been reported. While BBB permeability sufficient for MRI detection seems difficult to achieve for these Gd 3+ analogs, such probes with specific amyloid binding can be still useful in animal studies where BBB opening is feasible or in ex vivo MRI to stain Alzheimer brain tissues [51] .
Here we describe the synthesis of a novel ligand for Gd 3+ complexation, a H 5 DOTAGA (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-10-glutaric acid) conjugated with the PiB molecule through its amino group (L 4 , Scheme 1). This molecule contains a neutral ethylenediamine linker between the DOTA and the PiB moiety, like the DOTA-Eta-BTA ligand previously reported [50] ; however, we conjugated the PiB moiety via the amine group instead of via the hydroxyl function in DOTA-Eta-BTA. The objective of our work is to study in vitro the interaction of a charged Gd 3+ complex with the Aβ 1-40 peptide, its effect on the peptide aggregation process, and to compare it to neutral complexes previously investigated by us. We assessed the relevant physico-chemical parameters of Gd(L 4 ) with respect to a potential application as an MRI probe for Aβ amyloid detection (for simplicity, we used
− throughout the text). These studies include the assessment of (1) micelle formation in aqueous solution, (2) the parameters influencing relaxivity via an 17 O NMR and 1 H Nuclear Magnetic Relaxation Dispersion (NMRD) study and (3) the binding of the complex to serum albumin and to the aggregated form of Aβ 1-40 amyloid peptide using relaxometry. Surface Plasmon Resonance (SPR) was used to determine the affinity of Gd(L 4 ) to aggregated Aβ , while its interaction with the non-aggregated 15 N-Aβ peptide
Scheme 1 Chemical structure of Ln(L 4 ) studied here and related PiB conjugates previously reported was monitored by 1 H-15 N Heteronuclear Single Quantum Coherence (HSQC) NMR. Finally, the influence of the complex on the secondary structure and on the aggregation process of Aβ was investigated by Circular Dichroism (CD) and Transmission Emission Microscopy (TEM). These results are compared with previous studies for complexes of L 1 , L 2 and L 3 [46] [47] [48] and for those studied in Ref. [50] .
Materials and methods

Reagents and solutions
Chemicals were purchased from Sigma-Aldrich, Alfa Aesar and Chematech (DOTAGA anhydride) and used without further purification. Analytical grade solvents were used and were not further purified unless specified. The Aβ peptide (non-modified in the termini) was purchased from Polypeptide Group (Strasbourg, France).
Reactions were monitored by TLC on Kieselgel 60 F254 (Merck) on aluminum support.
1 H and 13 C NMR spectra were run on a Bruker Avance-500 (11.7 T) spectrometer, operating at 500.132 and 125.769 MHz, for 1 H and 13 C, respectively. High resolution mass spectrometry was performed on HRMS Q-Tof MaXis at the Centre de Biophysique Moléculaire du CNRS in Orléans, France.
Synthesis
Gd(L 4 ) was synthesized according to Scheme 2. The synthesis of the BTA derivative 1 was previously reported [46] . DOTAGA-6-methoxy-benzothiazol (L 4 ). A solution of DOTAGA-anhydride 2 (150 mg, 0.33 mmol) in 15 ml of DMF at 70 °C was put into reaction with a solution of the BTA derivative 1 (101 mg, 0.39 mmol) in the presence of triethylamine (3 equiv). The mixture was stirred at 100 °C during 16 h. After the evaporation of DMF, the crude solid was purified by reverse phase chromatography on C18. After evaporation of acetonitrile, the aqueous solution was lyophilized to afford 83 mg of ligand L 4 (35 % Gd(L 4 ) was prepared by mixing solutions of GdCl 3 and the ligand L 4 in equimolar quantities and adjusting the pH to 5 using aqueous NaOH (0.1 mM). The solution was allowed to react for 24 h at 60 °C while the pH was regularly controlled. The absence of free metal ion was checked in each sample using the xylenol orange test [52] 
Sample preparation
In the relaxometric HSA binding studies, 0.6 mM HSA (4 %) solutions were used. For the Aβ 1-40 binding studies, the peptide was added directly from the bottle to an equimolar solution of Gd(L 4 ) (200 µM) in 0.05 M HEPES buffer at pH 7 and the sample was sonicated. Milli-Q water was always used to avoid metal contamination. The sample containing the reconstituted peptide was used immediately to avoid degradation in solution.
15 N-labeled Aβ 1-40 peptide was purchased from AlexoTech (Umeå, Sweden). Deuterium oxide (99.9 %) was obtained from Cambridge Isotope Labs, UK. Sodium 2,2-dimethyl-2-silapentane-sulfonate (DSS, Stohler Isotope Labs, USA) was employed as NMR chemical shift reference at a final concentration of 50 μM. Aβ was were assessed by Proton Relaxation Enhancement (PRE) measurements. The PRE method is a non-separative technique in which the binding parameters can be obtained by exploiting the differences in the NMR water solvent relaxation rates between the bound and the unbound substrates [54, 55] . Since the relaxation rate is markedly increased in the presence of a paramagnetic substrate interacting with the protein, this method is perfectly tailored to investigate the binding of paramagnetic metal chelates. The proton relaxation rates R 1obs have been measured at increasing concentrations of the protein and the Gd(L 4 ) concentration was constant (0.1 mM). To obtain the affinity constant K A , the data are fitted to Eq. (1), where r 1 f and r 1 c are the proton relaxivities of the free and the bound state, c HSA and c 1 are the concentration of HSA and of the complex, respectively, and n is the number of binding sites on the protein.
calibration with a Pt resistance temperature probe. The longitudinal relaxation rates (1/T 1 ) were determined in water.
Measurements were performed at 25 and 37 °C.
O NMR spectroscopy
Variable temperature 17 O NMR measurements were performed on a 11 mM Gd(L 4 ) aqueous solution with a Bruker Avance-500 (11.7 T) spectrometer and a BVT-3000 temperature control unit was used to stabilize the temperature. The temperature was calculated according to a previous calibration with ethylene glycol and MeOH [53] . The samples were sealed in glass spheres that fitted into 10 mm o.d. NMR tubes, to eliminate susceptibility corrections to the chemical shifts [53] . Longitudinal relaxation rates 1/T 1 were obtained by the inversion recovery method and transverse relaxation rates 1/T 2 by the Carr-Purcell-MeiboomGill spin-echo technique. Acidified water of pH 3.4 was used as an external reference. 17 O-enriched water (10 % H 2 17 O, CortecNet) was added to the solutions to reach around 1 % enrichment.
The proton relaxation rates were measured using a Bruker WP80 NMR electromagnet adapted to variable field measurements and controlled by a SMARtracer PC-NMR console (40 MHz, 310 K).
Surface plasmon resonance
Real time binding studies of the Gd 3+ complex binding to immobilized Aβ by SPR spectroscopy were performed using a Biacore 3000 instrument (Biacore Life Sciences/GE Healthcare, Uppsala, Sweden) equipped with four flow cells on a sensor chip (Series S Sensor Chips CM5) and thermostated to 25 °C. N-hydroxysuc-
, ethanolamine HCl, sampling vials and caps were obtained from Biacore. Aβ 1-40 was dissolved in deionized water to a concentration of 1 mg/mL and small aliquots were frozen until use. HEPES buffered saline (HBS-EP) containing 0.01 mol/L HEPES, pH 7.4, 0.15 mol/L NaCl, 3 mmol/L EDTA, and 0.005 % of surfactant P20 was used as assay running buffer and for sample preparation.
The immobilization protocol of Aβ 1-40 to the CM5 chip followed standard amine coupling conditions [56] . The carboxymethyl dextran matrix in the sensor chip was activated by injection of a 1:1 mixture of EDC and NHS (70 μL, 200 mM EDC, 50 mM NHS) to allow the subsequent covalent cross linking of the injected peptide through primary amine groups forming amide bonds. The Aβ 1-40 solution (0.5 mg/mL peptide in sodium acetate buffer) was then injected into the activated flow cell. Unreacted NHS esters were capped with ethanolamine (70 μL, 1 M, pH 8.5) to afford a surface that gave a final change in resonance units (RU) of 4100 [56, 57] . Since 1000 RU determined by SPR corresponds to 1.0 pg/mm2 of bound ligand, the total immobilized mass of Aβ 1-40 under these conditions was approx. 4.1 pg/mm 2 . All binding data were collected with the biosensor instrument thermostated to 25 °C. To maximize the contact time, the flow rate in all steps was 20 µL/min. 140 µL of 0 to 2 mM solutions of the La(L 4 ) complexes in running buffer were injected for association (contact time 400 s). Dissociation was followed in the same buffer for 200 s. After each run, the sensor chip was regenerated with regeneration buffer (100 mM glycine-HCl in 10 mM Tris buffer (pH 9), contact time 240 s) and washed with running buffer for 5-10 min before the next injection. All buffers were filtered through 0.22 mm nylon filters (Millipore, USA) prior to use. The injection system was rinsed to change buffers when necessary. A Biacore 3000 control software (version 4.1) provided by Biacore Life Sciences/GE Healthcare was used to record and analyse the time dependence of the RUs (sensograms) and to plot binding curves. The control data were subtracted from the raw data obtained from the flow cell with immobilized Aβ . The response at equilibrium was then plotted versus concentration. The binding plots were fitted to a 1:1 Langmuir binding isotherm to obtain the dissociation constant (K D ) using the Biacore 3000 program.
Nuclear magnetic resonance
NMR spectra for characterizing Ln(L 4 ) interactions with Aβ 1-40 were recorded on a Bruker AV-600 spectrometer operating at 600. H signal based on the relative gyromagnetic ratios of these nuclei [61] .
Circular dichroism
The far-UV CD spectra were acquired on a Jasco J-810 CD spectropolarimeter equipped with a Jasco PTC-423S temperature control system. Measurements were performed at 3, 25 and 37 °C using a cell with a 1 mm optical path length. The spectral region was recorded from 190 to 260 nm with a step size of 0.5 and a bandwidth of 1 nm (1 mm optical path length). Data were collected with a time of 0.5 s per point, the spectra were averaged over 10 scans, and the buffer contribution was corrected. The samples contained 40 μM Aβ 1-40 peptide in 10 mM sodium phosphate buffer (pH 7.4) and 0-400 μM Gd 3+ -complex (corresponding to 0:1 to 10:1 molar ratio of Gd 3+ -complex to Aβ ). For the time-dependent experiments, the samples were stored on ice or at 3 °C, or in a Cole-Parmer Eppendorf heater at 25 and 37 °C throughout the incubation time.
Transmission electron microscopy
10 μL of an aggregated 40 μM Aβ 1-40 solution and 40 μM Aβ 1-40 + 160 μM Gd(L 4 ) (20 days after preparation, kept at 25 °C and pH 7.4) were deposited on Formvar/Cu 2+ grids and left for 2 min. Measurements were performed in parallel with the CD studies so we could translate directly our observations. The grids were washed twice with distilled filtered water. To stain the amyloid fibrils negatively, 10 μL aliquots of uranyl acetate 2 % (w/v) were deposited on the grid and left for 2 min before drying in air. Grids were stored at room temperature until examination in a Philips CM100 TEM microscope, operating at 80 keV. No evidences of Zn 2+ or Cu 2+ were detected.
Results and discussion
Synthesis
Ligand L 4 was prepared using the commercial DOTAGA anhydride 2, which was recently reported to be readily obtained in very high yield from DOTAGA. [62] This anhydride is very reactive and counterbalances the poor reactivity of the aromatic amine. The opening of the anhydride was demonstrated to be highly regioselective and, by reacting this derivative 2 with the benzothiazol moiety 1, only one step was necessary to obtain ligand L 4 with a yield of 35 %.
Determination of the critical micellar concentration by 1 H relaxivity measurements
The Gd(L x ) amphiphilic chelates form micellar aggregates in aqueous solution. We have previously determined the critical micellar concentration (cmc) for Gd(L 1 ) and Gd(L 3 ) complexes [46, 47] by relaxometric measurements [63] . The cmc of Gd(L 4 ) was obtained in a similar way by plotting the paramagnetic relaxation rate, R 1p , vs. the Gd(L 4 ) concentration at 40 MHz. This magnetic field maximizes the effect of slower rotation on relaxivity, thus making the relaxivity difference between the monomer and the aggregated state most apparent (Fig. 1) . At concentrations below the cmc, only the monomeric chelate contributes to the paramagnetic 1 H relaxation rate measured (Eq. 2). Here R 1 d is the diamagnetic contribution to the longitudinal relaxation rate, r 1 n.a represents the relaxivity of the free, non-aggregated Gd 3+ chelate (mM −1 s −1 ), and C Gd is the analytical Gd 3+ concentration.
Above the cmc, the measured relaxation rate is the sum of contributions from the monomer chelate present at a concentration given by the cmc, and from the aggregated form (micelles) as given by Eq. (3); r 1 a being the relaxivity of the micellar form.
The cmc is determined from a plot of the paramagnetic relaxation rates vs. the Gd 3+ concentration by a simultaneous least-squares fit of the two straight lines (Fig. 1) [47] c Parameters obtained at 60 MHz, 25 °C; from Ref. [64] Complex r 1 na (mM cmc. At low (0.2 mM) concentration, their form is characteristic of small-molecular weight complexes (Fig. 2a) . The relaxivity values (r 1 = 7.5 mM
s −1 at 20 MHz, 25 °C) are very similar to those reported for Gd(L x ) (x = 1,2,3,) complexes [47] , and, due to a slower rotation related to the presence of the bulky PiB moiety, they are ~50-60 % higher than those of clinical contrast agents [35] . Above the cmc, the NMRD profiles correspond to slowly tumbling systems with a typical high field peak around 40 MHz (Fig. 2b) . The proton relaxivities are influenced by water exchange rate, electron relaxation parameters and rotational correlation times, and to independently assess some of these, variable temperature 17 O NMR data have been also acquired. Figure 3 shows the temperature dependence of the reduced 17 O chemical shifts (Δω r ), transverse (1/T 2r ) and longitudinal (1/T 1r ) relaxation rates obtained for a 11.0 mM solution of Gd(L 4 ). Above 300 K, the transverse 17 O relaxation rates, 1/T 2r , increase with decreasing temperatures, indicating that here this complex is in the fast exchange regime. At lower temperatures, the transverse relaxation rates turn into a slow exchange regime. The reduced chemical shifts are in accordance with this trend. In the slow exchange regime, 1/T 2r is directly determined by the water exchange rate. In the fast exchange regime, it is also influenced by the longitudinal electronic relaxation rate, 1/T 1e , and the scalar coupling constant, A/ħ. The reduced 17 O chemical shifts are determined by A/ħ, and an outer sphere contribution, C os . Transverse 17 O relaxation is governed by the scalar relaxation mechanism, thus contains no information on the rotational motion of the system. In contrast, the longitudinal 17 O relaxation rates, 1/T 1r , are determined by dipole-dipole and quadrupolar relaxation mechanisms, both related to rotation.
The 17 O NMR and the NMRD data have been obtained at different concentrations where the aggregation states of the Gd(L 4 ) complex are different, therefore these data were analysed separately using the traditional SolomonBloembergen-Morgan theory [34, 35] . For the NMRD data, we have evaluated the curves both below and above the cmc (Fig. 2) . By analogy to similar complexes [34] and in accordance with the reduced 17 O chemical shifts in the fast exchange regime, monohydration was assumed for Gd(L 4 ).
Above the cmc, the proton relaxation rates measured represent the sum of the contributions of the monomer complex present at a concentration equal to the cmc, and of the aggregated state. The relaxivity of the aggregated form has been, thus calculated for each frequency point by subtracting the contribution of the monomer from the relaxation rates measured above cmc. The relaxivities calculated in this way for the micellar form have been fitted to the Solomon-Bloembergen-Morgan theory by including the Lipari-Szabo approach to interpret rotational dynamics. This model-free approach assumes that two kinds of motion modulate the relaxation process, a rapid, local motion which lies in the extreme narrowing limit and a slower, global motion. The correlation time for the global motion, common to the whole micelle, τ g , is separated from τ l , the correlation time for fast local motion. τ l is specific of the individual relaxation axis between the Gd-ion and the coordinated water H, and thus related to the motion of the individual Gd 3+ chelate units. The generalized order parameter, S 2 , is a model-independent measure of the degree of spatial restriction of the local motion, with S 2 = 0 if the internal motion is isotropic, and S 2 = 1 if the motion is completely restricted [64] . In the fit of the NMRD curves, we included only the relaxivities above 4 MHz, where the validity of the SBM theory is respected. The rate and the activation enthalpy of the water exchange were fixed to the values determined in the fit of the 17 O data ( Fig. 3 ; Table 2 ). The parameters describing electron spin relaxation, τ v 298 and Δ 2 , the correlation time for the modulation of the zero-fieldsplitting and the mean square ZFS energy, respectively, have been also adjusted in the fit of the NMRD data, but they are very poorly determined and the values should not be overinterpreted. Several other parameters have been fixed to typical values (the diffusion constant, D GdH 298 = 26al −10 m 2 s −1 ; its activation energy, E GdH = 20 kJ/mol; the Gdcoordinated water oxygen distance, r GdO = 2.5 Å, the Gdcoordinated water proton distance r GdH = 3.1 Å, the closest approach of outer sphere water protons to Gd 3+ , a GdH = 3.6 Å). The theoretical equations and the details of the analysis are shown in the Electronic Supplementary Material and the parameters obtained are given in Tables 2 and 3 .
Water exchange rate and rotational dynamics
The water exchange rate, directly determined from the 17 O T 2 data for Gd(L 4 ), k ex 298 = (9.7 ± 0.3) × 10 6 s −1 , is 3.5 times higher than that reported for Gd(L 3 ). This difference can be accounted for by the replacement of a carboxylate function of Gd(L 4 ) with an amide group in Gd(L 3 ) which is well-known to slow down water exchange by a factor of ~3 [34] . Interestingly, the exchange rate is about twice as high on Gd(L 4 ) than on GdDOTA, though both complexes are tetracarboxylates. This is likely related to the increased preference of Gd(L 4 ) for a twisted square antiprismatic (TSAP) structure. Indeed, DOTA-type Ln 3+ complexes exist in four stereoisomeric structures that, in LnDOTA chelates, are related as two enantiomeric pairs. The stereochemistry of these structures is defined by the conformation of the macrocyclic ring and by the orientation of the pendant arms. The same helicity of these two elements defines a monocapped twisted square antiprism (TSAP) coordination geometry, in contrast to an opposed helicity of the macrocycle and of the pendant arms for a monocapped square antiprism (SAP) structure. This TSAP isomer has markedly higher water exchange rate (up to 50-fold), as it has been documented for various examples. [65] [66] [67] [68] On the other hand, α substitution of the DOTA on the acetate CH 2 leads to a marked increase in the TSAP/SAP ratio for the Ln 3+ chelates in solution, the most studied example being the tetramethylated DOTA derivative, DOTMA [69] . For GdDOTMA, the observed water exchange rate is around 3-times higher than for GdDOTA, purely related to the increased proportion of the TSAP isomer [69] . As our L 4 ligand is also an α substituted derivative of DOTA, an increase of the TSAP ratio and consequently in the observed water exchange rate can be expected. Moreover, a bulky group is introduced in the α position which likely represents considerable constraint around the water binding site, leading to an accelerated exchange process in a dissociatively activated water exchange mechanism. [70] . The rotational dynamics are directly and individually assessed for both the monomer species and for the aggregated state by NMRD measurements. In contrast, the rotational correlation time calculated from the 17 O T 1 data corresponds to an average value with contributions from both the monomer and the aggregated state. The separation of local and global motions by the Lipari-Szabo treatment requires magnetic field dependent relaxation rates, thus cannot be applied for the analysis of our longitudinal 17 O relaxation data acquired at a single magnetic field. Nevertheless, the value of τ RO 298 = 857 ps clearly indicates slow rotation, in accordance with the massive proportion of the micellar form at this high concentration (11 mM). On the other hand, the NMRD profiles of the aggregated form could be analysed in terms of global and local rotation and these values characterize directly the micellar state.
The rotational correlation time obtained from the NMRD curves for the Gd(L 4 ) monomer is very close to those of Gd(L 1-3 ) monomers, all of approximately similar size, and they are all in accordance with their larger size with respect to Gd(DOTA) − . The average rotational correlation time as obtained from the 17 O T 1 data is higher for Gd(L 4 ) than that for the L 3 analog (Table 2) , which clearly reflects its slower rotation translated to ~25 % higher relaxivities for Gd(L 4 ) (at 40 MHz, see Table 1 ). A better insight into the rotational dynamics, and the differences between charged [Gd(L 4 )] and non-charged [Gd(L 1 ) and Gd(L 3 )] micelles can be obtained from the comparison of their local and global rotational correlation times and S 2 parameters (Table 3 ). An inspection of these data shows unambiguously that the charge of the amphiphilic chelate makes a remarkable difference in the structure and rigidity of the micellar aggregates formed in aqueous solution. Gd(L 4 ) bearing a negative charge forms markedly smaller micelles, with a global rotational correlation time, τ g 298 , which is 3-4 times lower than those for the neutral Gd(L 1 ) and Gd(L 3 ) micelles. Indeed, for systems of strictly analogous structures, the ratio of these global rotational correlation times could be related to the ratio of their molecular weight, as it has been previously evidenced for amphiphilic copolymers incorporating Gd 3+ complexes and forming micelles [64] . On the other hand, these micelles are more compact with a more restricted local motion of the Gd 3+ centers, as it is clearly shown by a sixfold increase in the local correlation time as compared to the non-charged micelles, accompanied by a doubling of the S 2 parameter, characterizing the restriction of the local with respect to the global motion. A very similar phenomenon has been previously observed when comparing dendrimers conjugated with negatively charged or neutral GdDOTA-type complexes [71] . At frequencies below 100 MHz, the proton relaxivities were twice as high for the dendrimers loaded with the negatively charged chelates in comparison with the analogous molecule bearing the neutral complexes. This difference was explained also by the different rotational dynamics: the negatively charged surface chelates create more rigidity of the system due to electrostatic repulsion and a consequently slower local motion. In overall, these structurally analogous micelles, together with the dendrimers cited above, provide a nice demonstration of how the charge of the chelate affects the relaxivity via the rotational dynamics of the nano-sized conjugates.
Relaxometric assessment of the interaction of Gd(L 4 ) with Human Serum Albumin (HSA) and Aβ 1-40 peptide
Upon binding of the monomeric form of Gd(L 4 ) to Aβ plaques, a relaxivity increase is expected, in particular at intermediate fields, since the complex becomes immobilized, and thus its rotational motion is restricted. Indeed, in the presence of the amyloid peptide Aβ 1-40 (c Gd = c Aβ1-40 = 0.2 mM), the relaxivity of Gd(L 4 ) increases considerably at magnetic fields where the effect of slower rotation is most pronounced (Fig. 4) . For instance, at 20 MHz the relaxivity approximately doubles, implying that the amyloid binding specifically contributes to a higher MRI [47] , Gd(L 4 ) interacts with serum albumin as well, reflected by the remarkable increase of relaxivity at intermediate fields (Fig. 4) . On one hand, strong albumin binding has a positive effect by preventing quick elimination of the agent from the body, but on the other hand, it reduces the BBB permeability of the agent [72] . We should note that HSA and Aβ are not direct competitors for binding, since they are not present in the same body compartments, except for the extremely small amount of Aβ that leaches out of the brain to the blood through a leaky BBB (Fig. 5) . The binding affinity of Gd(L 4 ) to HSA has been assessed by Proton Relaxation Enhancement (PRE) measurements commonly used to determine affinity constants of Gd 3+ complexes to HSA. Assuming one binding site in HSA (n = 1), a binding constant
and a relaxivity of the non-covalently bound complex r 1 c = 38.7 ± 5.3 s −1 mM −1 were obtained for Gd(L 4 ). Its affinity to HSA is up to one order of magnitude higher than for Gd(L 1 ) and Gd(L 3 ), possibly due to its negative charge, while the bound relaxivity is substantially lower and is in the order of those for well-established HSA binding probes such as GdBOPTA (Table 4) [46, 47] . To the best of our knowledge, the binding of the small molecule PiB itself to HSA has not been investigated.
We should note that HSA possesses multiple potential binding sites. Among the numerous Gd 3+ complexes with HSA-binding capability that have been investigated in the past, some were reported to bind to more than one independent sites with different binding constants [73, 74] . Relaxometric data do not allow for clearly distinguishing between different binding models. Ultrafiltration experiments are often used which typically show a superior affinity of one binding site with respect to the others (K a1 /K a2 between 15 and 30). Consequently, a 1:1 binding isotherm is used most commonly for the albumin binding of related Gd 3+ complexes [75] .
Binding studies of Ln(L 4 ) to Aβ 1-40
Surface Plasmon Resonance (SPR) was used to study the interaction of immobilized Aβ 1-40 with the La(L 4 ) complex using an immobilization protocol [76] which allows for probing the aggregated state of the peptide in solution. Figure 6 shows the SPR sensograms obtained for the binding of La(L 4 ) to the immobilized peptide and the corresponding binding plots. The fitting of these SPR plots to a simple 1:1 Langmuir binding isotherm gave a K D = 194 [46, 48] , indicating that the presence of a negative charge does not significantly influence the affinity of the complexes to the aggregated peptide. The conjugation of a metal chelate markedly reduces the binding affinity of the PiB to Aβ 1-40 aggregates, which is then two orders of magnitude lower than that of the positively charged ThT, and five orders of magnitude lower than that of the neutral PiB [22, 77] . Negatively charged Gd(DOTAGA) derivatives conjugated to PiB via the OH group directly or neutral chelates linked via a linker containing positively charged amino-acid residue (Lys or Arg) also have low affinities to Aβ aggregates [50] . Linkers with three positively charged lysine or arginine residues provide nevertheless stronger binding [50] . GdDTPA conjugated to modified human Aβ 1-40 also has higher in vitro affinity (K D = 0.577 μM) to Aβ aggregates [39] .
The interaction of the paramagnetic Gd(L 4 ) complex with Aβ 1-40 in the monomer state was studied by proteinbased NMR to identify the peptide regions involved in the interaction. For that purpose, we followed the changes in the 1D 1 H and 2D 1 H-15 N-HSQC spectra of 15 N-Aβ 1-40 upon the addition of aliquots of Gd(L 4 ) [78] [79] [80] [81] . These short time interval experiments were carried out at low temperature (5 °C) to minimize NMR signal loss due to amide hydrogen exchange with water and the effects resulting from peptide self-association. An expansion of the 1 H-15 N HSQC spectrum of 15 N-labeled Aβ alone is shown in Fig. 7 , which excludes the peaks due to the side chain H 2 N moieties of Gln 15 and Asn 27, and the peak arising from Arg 5's HNε. All the backbone HN groups appear in this spectrum, except the solvent exchange broadened resonances from D1, A2, H6 and H14 [82] . The absence of these peaks can therefore be attributed to solvent exchange broadening. The peak assignments correspond to previous reports [48, 78, 83, 84] . The addition of 0.5 and 1.0 equivalents of Gd(L 4 ) produced slight 1 H Aβ 1-40 resonance broadening and no apparent chemical shift changes. However, the presence of 4 eq of Gd(L 4 ) induced dramatic 1 H Aβ 1-40 line broadening (Figs. 7 and S1), as well as substantial peak broadening of Aβ 1-40 aromatic (7.5-6.5 ppm), beta (3.3-2.8 ppm) and aliphatic (2.4-0.7 ppm) proton signals as observed in the 1D spectra (Fig. 7) . All these observations are evidence that the monomeric forms of the polypeptide (present at low temperature and concentration) and of Gd(L 4 ) (present at concentrations below the cmc) strongly interact in solution. The dramatic change observed in some of the peptide signals as the concentration of Gd(L 4 ) is increased fourfold can be explained by a change of the peptide in solution from predominantly free to predominantly bound to Gd(L 4 ), as expected for a K d in the 200 μM range. The extensive line broadening observed most likely arises from the proximity of Aβ nuclei to the paramagnetic Gd +3 ion in the complex. However, we cannot rule out that the binding of Gd(L 4 ) to Aβ 1-40 might cause the polypeptide to adopt multiple conformations that interconvert on the μs-ms timescale, which would also produce line broadening. This titration experiment was repeated once and similar results were obtained.
These results contrast sharply with the effect of the neutral Gd(L 1 ) and Gd(L 2 ) complexes, which induce small or no changes on the 1 H-15 N HSQC spectrum of 15 N-Aβ 1-40 [48] , indicating the presence of very weak or no interactions of the complexes with the monomer form of the To assess the secondary structural changes of Aβ upon Ln(L 4 ) binding and how this affects the kinetics of Aβ aggregation in solution, we used far-UV CD spectroscopy [48, 78, 79, 81, 85, 86] . In CD measurements of proteins, the bands corresponding to the n → π* (~220 nm) and π → π* (~190 nm) electronic transitions involving the amide groups are very sensitive to secondary structural changes, and can be used to study them [87, 88] . The α-helical secondary structure is represented by a curve with an intense positive maximum residual molar elipticity at 193 nm and two negative minima at 208 and 222 nm, respectively. The β-sheet structure is recognized as a curve with a positive maximum at 195 nm and a weak negative minimum at 215 nm. The random coil structure is characterized by a strong negative minimum at 197 nm. Other less common structures are beta turns I and II, with positive maximum at 195 and 205 nm, respectively, and negative minima at 205 and 223 nm, respectively. Another structure, which is common for small peptides with random coil propensity, such as Aβ [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] , is the left-handed polyproline II (PPII) helix, also known as 3 1 helix, characterized by a strong negative minimum at 197 nm and a weak positive band at 220 nm [86, 89] .
We started by performing CD experiments for free Aβ 1-40 as a function of time at 3, 25 °C and 37 °C ( Figure S2 ). At 3 °C, the initial CD spectra of free monomeric Aβ showed a predominant random coil contribution (minimum at 197 nm) with a significant contribution from the PPII helix (small maximum at 220 nm), in agreement with the literature [48, 89, 90] , which estimated a PPII content of 43 % at 0 °C [89] . The CD spectrum at 3 °C did not change for 5 days, but after 20 days the intensity of the whole spectrum decreased, perhaps due to light scattering from formation of larger particles. At 37 °C, the initial CD spectrum corresponds more closely to a random coil conformation, with a marked decrease of the PPII contribution [48, 49] . At these higher temperatures, the CD spectrum evolves more rapidly with time. For instance, at 37 °C this evolution starts after 2 h, and the α-helix is clearly predominant at 52 h, while the β-sheet structure becomes predominant after 20 days.
The time evolution of the CD spectra of Aβ was also investigated in the presence of increasing concentrations (0, 40, 80, 160, and 400 µM) of Gd(L 4 ), at 3, 25 and 37 °C, and at different time points (0, 2, 4, 24, 48 h, 5, 20 days). We only observed clear changes to ordered α-helix and β-sheet structures for times longer than 2 h and at 25 and 37 °C. Comparison of the data at 20 days (Fig. 8) suggests that, at 37 °C, Gd(L 4 ) stabilizes the random coil relative to the α-helix and β-sheet at all ratios, thus slows down the aggregation process. This is in contrast with the evolution of the peptide in the absence of the complex, where after 20 days at 37 °C the β-sheet structure predominates relative to the α-helix and random coil. Thus, Gd(L 4 ) has an effect on the secondary structure of Aβ similar to that of lacmoid [79] or Gd(L 1 ) [48] , which protect the peptide against forming ordered structures. While this is an interesting phenomenon, it does not have any direct implication for the imaging potential of the probe.
The CD experiments show that Gd(L 4 ) stabilizes (and presumably binds to) the random coil conformation of Aβ . Since this conformation corresponds to the monomeric form, this is in reasonable agreement with the NMR HSQC results, which detect changes that can be ascribed to conformational transitions within the random coil ensemble, but not a conversion into α-helix or β-sheet. The NMR experiments carried out here would not detect the slow processes detected by CD at long times.
Aggregation studies of Aβ 1-40 by transmission electron microscopy
TEM was used to monitor the fibrillar evolution of Aβ . After 20 days of incubation (25 °C) of Aβ 1-40 alone or in the presence of 160 μM Gd(L 4 ), TEM images (Fig. 9) suggest higher quantities of organized Aβ structures in the control Aβ samples than in the presence of Gd(L 4 ). Gd(L 4 ) shows an inhibitory effect on β-amyloid aggregation, similarly to lacmoid [79] , or Gd(L 3 ) [48] and in contrast to CR [78] or Gd(L 1 ) [48] . Such a reduction of fibril formation in the presence of Gd(L 4 ) is consistent with the probe binding to the monomeric peptide, as shown by the NMR and CD data. Data indicate that negatively charged molecules interacting with amyloid peptides do not necessarily represent the driving force for pre-fibrillation and aggregation. It also shows that the Aβ adopted structure is strictly connected to the ligand design that plays a key role towards the aggregation process. Evidence was recently presented that the Gd(III)-curcumin complex could modulate Cu(II)-triggered Aβ aggregation more noticeably over metal-free or Zn(II)-induced analogs [91] .
Conclusions
A tetracarboxylate-derivative DOTA chelate has been conjugated to the PiB moiety that is known to specifically recognize amyloid Aβ peptides. This ligand yields a negatively charged Gd 3+ complex, Gd(L 4 ), which was characterized with respect to its relaxation properties important for MRI application and to its binding capability to Aβ and human serum albumin. These data have been compared to those obtained for previously reported analogous complexes which are neutral. Gd(L 4 ) forms micelles in aqueous solution that are smaller, but considerably less flexible than those formed by their neutral counterparts, as evidenced by a detailed description of their rotational dynamics using the Lipari-Szabo treatment to analyze proton relaxation rates. The negative charge has limited effect on the binding affinity to aggregated Aβ , while it increases by one order of magnitude the binding strength to human serum albumin. Based on TEM images and time-and temperature-dependent circular dichroism data, Gd(L 4 ) seems to reduce the formation of Aβ 1-40 amyloid fibrils. Although the complex promotes the disaggregation of the peptide in vitro, such a breaking process in vivo would be negligible, as it requires the long-term accumulation of the probe in the Aβ plaques, and the dissociation kinetics for Aβ protofibrils and fibrils is very slow [92, 93] . Finally, protein-based NMR suggested that there is also interaction of the paramagnetic Gd(L 4 ) complex with Aβ in the monomer state, in contrast to what was previously observed for the neutral complexes. However, it still binds tighter to the aggregated form of Aβ .
A connection has been recently discovered between the lymphatic system and the brain [94] , which might be exploited to get amyloid-specific probes into the brain without having to cross the BBB. In addition, there is evidence that the AD brain might be leaky, to various extents as a function of the progress of the disease [95] [96] [97] . If the brain is highly leaky, a contrast agent can enter the brain, however, this might not be the case in early phases of the disease. Therefore, our approach clearly cannot be applied to very early detection of AD. Due to the BBB leakiness, Aβ peptides can be indeed found in the blood, mainly as monomers and dimers, however, at very low concentration (pM) [98, 99] , which is not adapted for MRI detection. Considering this and the fact that HSA concentration in blood is several orders of magnitude higher, the detection of Aβ leaked out into the blood is also not feasible by MRI using chelates such as Gd(L 4 ).
In overall, these data afford novel insights into the behavior of amyloid peptides in the presence of metal complexes for a potential imaging application. In addition, probes such as Gd(L 4 ) are likely not adapted for early MRI detection of AD in humans, but can be helpful in in vivo animal studies with BBB opening and for ex vivo MRI.
